Contraindications and Adverse Events

Contraindications define the circumstances in which a vaccine should not be given because the risk outweighs the benefit, while adverse events following immunization are any untoward medical occurrences after vaccination, whether or not they are caused by the vaccine. Distinguishing genuine contraindications from temporary precautions, and true vaccine reactions from coincidental events, is central to safe immunization practice.

Definition

A contraindication is a condition in a recipient that substantially increases the risk of a serious adverse reaction and so precludes giving a vaccine; a precaution is a condition that may increase risk or reduce response and warrants caution or deferral. An adverse event following immunization (AEFI) is any untoward medical occurrence after vaccination that does not necessarily have a causal relationship with the vaccine.

Scope

This entry explains the concepts of contraindications and precautions, the spectrum of adverse events following immunization, and how surveillance systems detect and evaluate safety signals. It is an educational overview of how vaccine safety is framed and monitored; it does not list which conditions contraindicate which vaccine for an individual, as those determinations are set by current recommendations and clinical judgement.

Core questions

• What is the difference between a true contraindication, a precaution, and a condition that is mistakenly believed to contraindicate vaccination?
• What is the spectrum of adverse events following immunization, from common local reactions to rare serious events?
• How is a causal relationship between a vaccine and an event distinguished from coincidence?
• How do passive and active surveillance systems detect and evaluate vaccine-safety signals?
• How does the perception and communication of adverse events affect vaccine confidence?

Key concepts

• Contraindication versus precaution
• Adverse event following immunization (AEFI)
• Causality assessment
• Coincidental versus causal events
• Local versus systemic reactions
• Passive surveillance (spontaneous reporting)
• Active and post-licensure safety monitoring
• Benefit-risk balance

Mechanisms

Adverse events following immunization range from common, self-limited local and systemic reactions to rare serious events; because many events would occur anyway in a vaccinated population, causality cannot be inferred from temporal association alone and must be assessed against background rates and biological plausibility (Shimabukuro, 2015). Contraindications and precautions identify recipients in whom a specific vaccine carries elevated risk or is expected to perform poorly, such as certain live-vaccine considerations in immunocompromise (Rubin, 2014). Safety is monitored through complementary systems: passive, spontaneous reporting such as the Vaccine Adverse Event Reporting System (VAERS) generates hypotheses and detects signals, which are then evaluated in active, population-based surveillance (Shimabukuro, 2015).

Clinical relevance

Recognising true contraindications and precautions, counselling on expected reactions, and reporting significant adverse events are core to safe immunization practice. This entry describes how contraindications and adverse events are conceptualised and monitored; it does not specify contraindications for any vaccine or person, which are governed by current authoritative recommendations and the clinician.

Epidemiology

Serious adverse reactions to vaccines are rare relative to the diseases they prevent, but their detection requires large-scale surveillance because background medical events are common in vaccinated populations (Shimabukuro, 2015). Misattribution of coincidental events to vaccines, and amplified concern about rare reactions, can erode vaccine confidence and reduce uptake, underscoring the importance of transparent safety monitoring and communication (Larson, 2011).

History

Structured vaccine-safety surveillance developed as immunization programmes expanded and rare adverse events needed systematic detection. Spontaneous reporting systems such as VAERS, established to capture reports after licensure, were complemented by active, linked-database surveillance to evaluate signals against background rates (Shimabukuro, 2015).

Debates

How should rare adverse events be communicated without eroding confidence?

Transparent reporting of rare adverse events is essential to trust, yet emphasis on rare risks relative to the much larger benefits of vaccination can fuel hesitancy; balancing candour with proportionate framing of benefit and risk is an ongoing challenge.

Key figures

• Tom T. Shimabukuro
• Frank DeStefano
• Heidi J. Larson

Seminal works

• shimabukuro-2015
• rubin-2014

Frequently asked questions

What is the difference between a contraindication and a precaution?

A contraindication is a condition that substantially raises the risk of a serious reaction, so the vaccine should not be given. A precaution is a condition that may increase risk or reduce the response and calls for caution or deferral rather than an absolute bar; the specifics for any vaccine are set by current recommendations.

Does an event happening after vaccination mean the vaccine caused it?

Not necessarily. An adverse event following immunization is any medical event after vaccination, and because such events also occur without vaccination, causality must be assessed by comparing rates against background expectations rather than from timing alone (Shimabukuro, 2015).